Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review

• Toshi A Furukawa,
• Kiyomi Shinohara,
• Aran Tajika,
• Stefan Leucht,
• Rie Toyomoto,
• Kazufumi Yoshida,
• Johannes Schneider-Thoma,
• Masami Ito,
• Yuki Furukawa,
• Shino Kikuchi,
• Yukiko Honda,
• Tomohiro Takayama

Affiliations

Toshi A Furukawa

Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan

Kiyomi Shinohara

1 Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan

Aran Tajika

5 Department of Psychiatry, Kyoto University Hospital, Kyoto, Japan

Stefan Leucht

Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany

Rie Toyomoto

1 Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Kyoto, Japan

Kazufumi Yoshida

Departments of Health Promotion and Human Behavior and Clinical Epidemiology, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan

Johannes Schneider-Thoma

Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany

Masami Ito

Department of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan

Yuki Furukawa

Department of Psychiatry, Tokyo Musashino Hospital, Tokyo, Japan

Shino Kikuchi

1 Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Kyoto, Japan

Yukiko Honda

3 Department of Community Medicine, Nagasaki University School of Medicine Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan

Tomohiro Takayama

4 Faculty of Medicine, Kyoto University, Kyoto, Kyoto, Japan